Maryland-based United Therapeutics has inked a licence, development and commercialisation agreement with CollPlant, an Israeli biotech company, for 3D bioprinted lung transplants.
Novartis has teamed up with a clinical-stage biopharmaceutical firm in efforts to bring the Swiss company’s proprietary cancer treatment to patients in China.
The Bombay High Court has imposed Rs 1.5 crore of costs on a pharmaceutical company which infringed India-based Glenmark Pharmaceuticals’ trademarks.
Two Chinese nationals have been charged with conspiracy to steal rice technology from a US-based biotechnology company.
Spain-based pharmaceutical company Almirall will acquire Allergan’s dermatology portfolio.
In India, a non-profit organisation and an advocacy group have united to take on a patent covering pibrentasvir, part of the drug combination that forms AbbVie’s hepatitis C product Mavyret.
Dusa Pharmaceuticals, a subsidiary of India-based generic drug maker Sun Pharma, has accused dermatology-focused company Biofrontera of misappropriating trade secrets.
A medical technology trade association has warned that the US tariffs recently implemented in response to Chinese IP theft may hinder patient access to life-saving technologies.
The US is leading the way in synthetic biology patent filings, according to a report released earlier this month from patent search software company PatSnap.
Humanitarian organisation Médecins Sans Frontières has challenged a patent owned by Gilead in China.